Freedom I (NYSE:FACT) announced this morning that it has closed its combination with residential solar developer Complete Solaria and the combined company’s shares and warrants are expected to trade on the Nasdaq under the symbols “CSLR” and “CSLRW” later today, July 18.
The news comes after Freedom I secured new funding last week through a mix of PIPE investments, non-redemption agreements and forward purchase agreements. These resulted in the about $80 million gross proceeds for Complete Solaria.
The SPAC had secured shareholder approval of the deal two days earlier, but 99% redemptions had left Freedom I with just 335,492 shares remaining and about $3.5 million in trust.
Freedom I may still have fallen short of the deal’s initial minimum cash condition of $100 million, but it will also bring significant experience to the company’s Board post-close. The SPAC’s Executive Chairman Tidjane Thiam and CEO Adam Gishen are to come aboard bringing years of experience as Credit Suisse’s CEO and head of investor relations, respectively.
Complete Solaria has already made use of other incoming expertise in streamlining operations this year.
It announced in a June 30 business update that production bottlenecks it encountered in the first quarter of the year were cleared in Q2 with the company projected to reach about $1.2 million in daily revenue by the end of the period.
ADVISORS
- Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acted as lead capital markets advisor to Freedom.
- Janney Montgomery Scott LLC acted as capital markets advisor to Freedom.
- Cooley LLP served as legal advisor to Complete Solaria.
- Paul Hastings LLP served as legal advisor to Freedom.
- Duff and Phelps provided a fairness opinion to the Board of Directors of Freedom in connection with the business combination with Complete Solaria.
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...
Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...
At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...